Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

Vera G. Kalugina; Elena A. Vishneva; Leyla S. Namazova-Baranova

Pediatric pharmacology
Pediatričeskaâ farmakologiâ

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

User

eng | рус

Pediatric pharmacology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Kalugina V.G., Vishneva E.A., Namazova-Baranova L.S. Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study. Pediatric pharmacology. 2020;17(3):179-186. (In Russ.) https://doi.org/10.15690/pf.v17i3.2122

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Editor-in-Chief

Leyla S. Namazova-Baranova

Popular articles

* not an advertisement

Indexing Databases

* not an advertisement

Article Tools

Abstract

Print this article

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

Vera G. Kalugina
Research Institute of Pediatrics and Children’s Health in Central Clinical Hospital of Russian Academy of Sciences
Russian Federation

Moscow

Elena A. Vishneva
Research Institute of Pediatrics and Children’s Health in Central Clinical Hospital of Russian Academy of Sciences; Pirogov Russian National Research Medical University
Russian Federation

Moscow

Leyla S. Namazova-Baranova
Research Institute of Pediatrics and Children’s Health in Central Clinical Hospital of Russian Academy of Sciences; Pirogov Russian National Research Medical University; Belgorod State National Research University
Russian Federation

Moscow

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

For citations:

Cookies policy